TheraVet Provides Its 2021 Second Half Operational Update
Regulatory News: TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 ticker: ALVET), a pioneering biotechnology company specialising in the management of osteoarticular diseases in pets
United States France General Bruxelles Capitale Waals Gewest Christian Schirvel Martin Olivier Bricaud
Source: finanznachrichten.de